Search Results - "Vakili, B A"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Prognostic implications of left ventricular hypertrophy by Vakili, Babak A., Okin, Peter M., Devereux, Richard B.

    Published in The American heart journal (01-03-2001)
    “…Background To date there has been no comprehensive review of the association between left ventricular hypertrophy (LVH) at baseline and subsequent adverse…”
    Get full text
    Journal Article
  2. 2

    Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state by Vakili, B A, Kaplan, R, Brown, D L

    Published in Circulation (New York, N.Y.) (30-10-2001)
    “…An inverse relation exists between the number of coronary angioplasty procedures performed by physicians or hospitals and short-term mortality. It is not…”
    Get full text
    Journal Article
  3. 3

    Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction by VAKILI, Babak A, KAPLAN, Robert C, BROWN, David L

    Published in Circulation (New York, N.Y.) (18-12-2001)
    “…Morbidity and mortality after an acute myocardial infarction (AMI) has been reported to be higher in women than men. However, in some prior reports, women were…”
    Get full text
    Journal Article
  4. 4

    Comparison of in-hospital outcomes after coronary angioplasty with or without stent placement for acute myocardial infarction by Vakili, Babak A, Brown, David L

    Published in The American journal of cardiology (01-11-2000)
    “…This study compared the in-hospital outcomes of patients treated with or without stent placement during mechanical revascularization for acute myocardial…”
    Get full text
    Journal Article
  5. 5

    Clinical and Biochemical Results of the Metalloproteinase Inhibition with Subantimicrobial Doses of Doxycycline to Prevent Acute Coronary Syndromes (MIDAS) Pilot Trial by Brown, David L, Desai, Kavita K, Vakili, Babak A, Nouneh, Chadi, Lee, Hsi-Ming, Golub, Lorne M

    “…BACKGROUND—Vulnerable plaque demonstrates intense inflammation in which macrophages secrete matrix metalloproteinases (MMPs) that degrade the fibrous cap,…”
    Get full text
    Journal Article
  6. 6

    Effect of diabetes on long-term mortality Following contemporary percutaneous coronary intervention analysis of 4,284 cases by WILSON, Sean R, VAKILI, Babak A, SHRRMAN, Warren, SANBORN, Timothy A, BROWN, David L

    Published in Diabetes care (01-05-2004)
    “…Diabetic patients are known to have reduced long-term survival following percutaneous transluminal coronary angioplasty compared with nondiabetic patients…”
    Get full text
    Journal Article
  7. 7

    Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease by Nayak, D U, Karmen, C, Frishman, W H, Vakili, B A

    Published in Heart disease (Hagerstown, Md.) (01-01-2001)
    “…Oxygen-derived free radical formation can lead to cellular injury and death. Under normal situations, the human body has a free radical scavenger system…”
    Get more information
    Journal Article
  8. 8
  9. 9

    In-hospital outcomes of contemporary percutaneous coronary interventions in the very elderly by Dynina, Olga, Vakili, Babak A., Slater, James N., Sherman, Warren, Ravi, Kumar L., Green, Stephen J., Sanborn, Timothy A., Brown, David L.

    “…Coronary heart disease is the leading cause of death among the elderly (> 65 years) and the very elderly (> 85 years). Little information is available…”
    Get full text
    Journal Article
  10. 10

    A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention by Vakili, Babak A, Kaplan, Robert C, Slater, James N, Sherman, Warren, Ravi, Kumar L, Green, Stephen J, Sanborn, Timothy A, Brown, David L

    Published in The American journal of cardiology (15-04-2003)
    “…It is unknown whether the benefits of parenteral platelet glycoprotein (GP) IIb/IIIa inhibitors as an adjunct to percutaneous coronary intervention (PCI)…”
    Get full text
    Journal Article